Literature DB >> 18650354

Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006.

A Kroneman1, L Verhoef, J Harris, H Vennema, E Duizer, Y van Duynhoven, J Gray, M Iturriza, B Böttiger, G Falkenhorst, C Johnsen, C-H von Bonsdorff, L Maunula, M Kuusi, P Pothier, A Gallay, E Schreier, M Höhne, J Koch, G Szücs, G Reuter, K Krisztalovics, M Lynch, P McKeown, B Foley, S Coughlan, F M Ruggeri, I Di Bartolo, K Vainio, E Isakbaeva, M Poljsak-Prijatelj, A Hocevar Grom, J Zimsek Mijovski, A Bosch, J Buesa, A Sanchez Fauquier, G Hernandéz-Pezzi, K-O Hedlund, M Koopmans.   

Abstract

The Foodborne Viruses in Europe network has developed integrated epidemiological and virological outbreak reporting with aggregation and sharing of data through a joint database. We analyzed data from reported outbreaks of norovirus (NoV)-caused gastroenteritis from 13 European countries (July 2001 to July 2006) for trends in time and indications of different epidemiology of genotypes and variants. Of the 13 countries participating in this surveillance network, 11 were capable of collecting integrated epidemiological and virological surveillance data and 10 countries reported outbreaks throughout the entire period. Large differences in the numbers and rates of reported outbreaks per country were observed, reflecting the differences in the focus and coverage of national surveillance systems. GII.4 strains predominated throughout the 5-year surveillance period, but the proportion of outbreaks associated with GII.4 rose remarkably during years in which NoV activity was particularly high. Spring and summer peaks indicated the emergence of genetically distinct variants within GII.4 across Europe and were followed by increased NoV activity during the 2002-2003 and 2004-2005 winter seasons. GII.4 viruses predominated in health care settings and in person-to-person transmission. The consecutive emergence of new GII.4 variants is highly indicative of immune-driven selection. Their predominance in health care settings suggests properties that facilitate transmission in settings with a high concentration of people such as higher virus loads in excreta or a higher incidence of vomiting. Understanding the mechanisms driving the changes in epidemiology and clinical impact of these rapidly evolving RNA viruses is essential to design effective intervention and prevention measures.

Entities:  

Mesh:

Year:  2008        PMID: 18650354      PMCID: PMC2546741          DOI: 10.1128/JCM.00499-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Evidence of recombination in the norovirus capsid gene.

Authors:  Jacques Rohayem; Julia Münch; Axel Rethwilm
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004.

Authors:  Lenee H Blanton; Susan M Adams; R Suzanne Beard; Gang Wei; Sandra N Bulens; Marc-Alain Widdowson; Roger I Glass; Stephan S Monroe
Journal:  J Infect Dis       Date:  2005-12-21       Impact factor: 5.226

3.  Norovirus classification and proposed strain nomenclature.

Authors:  Du-Ping Zheng; Tamie Ando; Rebecca L Fankhauser; R Suzanne Beard; Roger I Glass; Stephan S Monroe
Journal:  Virology       Date:  2005-12-15       Impact factor: 3.616

4.  Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis.

Authors:  Rowena A Bull; Elise T V Tu; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Genetic diversity of norovirus among children with gastroenteritis in São Paulo State, Brazil.

Authors:  Juliana Galera Castilho; Veridiana Munford; Hugo Reis Resque; Ulysses Fagundes-Neto; Jan Vinjé; Maria Lúcia Rácz
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

6.  Molecular epidemiology of norovirus outbreaks in Norway during 2000 to 2005 and comparison of four norovirus real-time reverse transcriptase PCR assays.

Authors:  Kirsti Vainio; Mette Myrmel
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  SurvNet@RKI--a multistate electronic reporting system for communicable diseases.

Authors:  D Faensen; H Claus; J Benzler; A Ammon; T Pfoch; T Breuer; G Krause
Journal:  Euro Surveill       Date:  2006

8.  Epidemic spread of recombinant noroviruses with four capsid types in Hungary.

Authors:  Gábor Reuter; Harry Vennema; Marion Koopmans; György Szücs
Journal:  J Clin Virol       Date:  2005-10-19       Impact factor: 3.168

9.  Evidence of the etiological predominance of norovirus in gastroenteritis outbreaks--emerging new-variant and recombinant noroviruses in Hungary.

Authors:  Gábor Reuter; Katalin Krisztalovics; Harry Vennema; Marion Koopmans; György Szucs
Journal:  J Med Virol       Date:  2005-08       Impact factor: 2.327

10.  Risk groups for clinical complications of norovirus infections: an outbreak investigation.

Authors:  F Mattner; D Sohr; A Heim; P Gastmeier; H Vennema; M Koopmans
Journal:  Clin Microbiol Infect       Date:  2006-01       Impact factor: 8.067

View more
  87 in total

1.  Two-year systematic study to assess norovirus contamination in oysters from commercial harvesting areas in the United Kingdom.

Authors:  James A Lowther; Nicole E Gustar; Andrew L Powell; Rachel E Hartnell; David N Lees
Journal:  Appl Environ Microbiol       Date:  2012-06-08       Impact factor: 4.792

2.  Surveillance of Noroviruses in Rio De Janeiro, Brazil: Occurrence of New GIV Genotype in Clinical and Wastewater Samples.

Authors:  Julia Monassa Fioretti; Tulio Machado Fumian; Mônica Simões Rocha; Ingrid de Arruda Lucena Dos Santos; Filipe Aníbal Carvalho-Costa; Matheus Ribeiro de Assis; Janaina de Souza Rodrigues; José Paulo Gagliardi Leite; Marize Pereira Miagostovich
Journal:  Food Environ Virol       Date:  2017-06-21       Impact factor: 2.778

Review 3.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

4.  Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006.

Authors:  Du-Ping Zheng; Marc-Alain Widdowson; Roger I Glass; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

5.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

6.  Zeta Potential and Aggregation of Virus-Like Particle of Human Norovirus and Feline Calicivirus Under Different Physicochemical Conditions.

Authors:  Idrissa Samandoulgou; Ismaïl Fliss; Julie Jean
Journal:  Food Environ Virol       Date:  2015-05-23       Impact factor: 2.778

Review 7.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

Review 8.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

9.  Evaluation of the microbiological quality of reclaimed water produced from a lagooning system.

Authors:  X Fernandez-Cassi; C Silvera; S Cervero-Aragó; M Rusiñol; F Latif-Eugeni; C Bruguera-Casamada; S Civit; R M Araujo; M J Figueras; R Girones; S Bofill-Mas
Journal:  Environ Sci Pollut Res Int       Date:  2016-05-19       Impact factor: 4.223

10.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.